Structure and Function of the LPLA2/LCAT Acyltransferase Family
LPLA2/LCAT 酰基转移酶家族的结构和功能
基本信息
- 批准号:9174909
- 负责人:
- 金额:$ 48.34万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2014
- 资助国家:美国
- 起止时间:2014-11-04 至 2017-08-13
- 项目状态:已结题
- 来源:
- 关键词:Active SitesAcyltransferaseAddressAdverse effectsAffectAlveolar MacrophagesAmiodaroneAnti-Arrhythmia AgentsApolipoprotein A-IAtherosclerosisAutoimmune DiseasesBindingBiological AssayBiological Response Modifier TherapyCatabolismCatalysisCationsCholesterolCholesterol EstersClinicalComplexCryoelectron MicroscopyCrystallizationDNA Sequence AlterationDevelopmentDiseaseElectron MicroscopyEngineeringEnzymesEye diseasesFamilyFishesFutureGlycerophospholipidsGoalsHereditary DiseaseHigh Density LipoproteinsHumanImageInfusion proceduresKidney FailureKnowledgeLeadLearningLigandsLipaseLipidsLipoprotein (a)Lipoprotein BindingLiposomesLiverMapsMembraneModelingMolecularMutationNegative StainingOutcome StudyPatientsPharmaceutical PreparationsPhosphatidylcholine-Sterol O-AcyltransferasePhospholipase A2PhysiologicalPlasma ProteinsPlayPositioning AttributeProteinsPulmonary SurfactantsReactionRecombinantsRegulationReportingResolutionRoleSeriesSerumSite-Directed MutagenesisSomatic MutationStructureSurfaceTestingTransacylaseVariantacute coronary syndromeanalogataxia telangiectasia mutated proteinbasecrystal-8designdisease phenotypeenzyme replacement therapyesterasefamilial cholesteryl ester deficiencyflexibilityimprovedinsightlecithin cholesterol acyltransferase deficiencylipid metabolismlipophilicitymacrophageparticlepeptidomimeticspreclinical studypublic health relevancereconstructionreverse cholesterol transportsmall moleculetheoriestherapy design
项目摘要
DESCRIPTION (provided by applicant): Lysosomal phospholipase A2 (LPLA2) plays a major role in lipid degradation and is believed to underlie drug-induced phospholipidosis, which commonly occurs in patients taking cationic lipophilic drugs such as the antiarrhythmic amiodarone. Aberrant LPLA2 activity may also be involved in development of autoimmune disease and atherosclerosis. LPLA2 is 50% identical in sequence to lecithin-cholesterol acyltransferase (LCAT), a key enzyme in reverse cholesterol transport from arterial plaque macrophages via high density lipoproteins (HDL). Genetic mutations in LCAT are responsible for Familial LCAT Deficiency (FLD), a devastating disease characterized by low serum cholesterol ester levels and renal failure. There are no reported atomic models for either LPLA2 or LCAT, which do not have significant homology to other proteins of known structure. Thus, the molecular bases for their substrate selectivity, regulation, and disease phenotypes remain poorly understood. In this proposal, we address this critical gap in knowledge via functional analysis of our new 1.8 � crystal structure of LPLA2, determination of the atomic structure of LCAT, imaging LCAT bound to HDL particles by electron microscopy, mapping somatic mutations known to cause genetic disease, and investigating the structural basis for differences in acyl acceptor selectivity. In support of our aims, we provide multiple high resolution structure of LPLA2 in various ligand states, negative stained images of LCAT-HDL complexes, and a low resolution crystal structure of fully glycosylated LCAT. The expected outcome of these studies is a better mechanistic understanding of a structurally uncharacterized family of eukaryotic enzymes that play key roles in lipid metabolism. Our structural and functional studies will help explain the molecular basis for genetic disease and ultimately assist in the design of improved biotherapeutics and small molecule LCAT activators to treat lipid-related disorders such as atherosclerosis and LCAT deficiency.
描述(申请人提供):溶酶体磷脂酶A2(LPLA2)在脂质降解中起主要作用,被认为是药物引起的磷脂沉积症的基础,通常发生在服用阳离子亲脂性药物的患者,如抗心律失常的胺碘酮。LPLA2活性异常也可能参与自身免疫性疾病和动脉粥样硬化的发生。LPLA2在序列上与卵磷脂-胆固醇酰基转移酶(LCAT)有50%的同源性,LCAT是通过高密度脂蛋白(HDL)从动脉斑块巨噬细胞反向运输胆固醇的关键酶。LCAT基因突变是家族性LCAT缺乏症(FLD)的原因,FLD是一种以低血清胆固醇酯水平和肾功能衰竭为特征的破坏性疾病。目前还没有关于LPLA2或LCAT的原子模型的报道,这些模型与其他已知结构的蛋白质没有显著的同源性。因此,它们的底物选择性、调节和疾病表型的分子基础仍然知之甚少。在这项建议中,我们通过对LPLA2的新的1.8�晶体结构的功能分析、确定LCAT的原子结构、通过电子显微镜对LCAT与高密度脂蛋白颗粒结合的成像、定位已知导致遗传疾病的体细胞突变以及研究酰基受体选择性差异的结构基础来解决这一关键的知识缺口。为了支持我们的目标,我们提供了LPLA2在不同配体状态下的多种高分辨率结构,LCAT-高密度脂蛋白复合体的负染图像,以及完全糖基化的LCAT的低分辨率晶体结构。这些研究的预期结果是更好地从机制上理解结构上没有特征的真核酶家族,这些酶在脂类代谢中发挥关键作用。我们的结构和功能研究将有助于解释遗传病的分子基础,并最终帮助设计改进的生物疗法和小分子LCAT激活剂来治疗脂质相关疾病,如动脉粥样硬化和LCAT缺乏症。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
John Tesmer其他文献
John Tesmer的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('John Tesmer', 18)}}的其他基金
New X-ray Diffractometer and Detector for Purdue Macromolecular Crystallography
用于普渡大学高分子晶体学的新型 X 射线衍射仪和探测器
- 批准号:
10431439 - 财政年份:2022
- 资助金额:
$ 48.34万 - 项目类别:
GPCR - Linked RhoGEFs in Tumor Growth and Metastasis
GPCR - 连接 RhoGEF 在肿瘤生长和转移中的作用
- 批准号:
10338123 - 财政年份:2018
- 资助金额:
$ 48.34万 - 项目类别:
FASEB SRC on G Protein-Coupled Receptor Kinases and Arrestins: From Structure to Disease
FASEB SRC 关于 G 蛋白偶联受体激酶和抑制蛋白:从结构到疾病
- 批准号:
9330648 - 财政年份:2017
- 资助金额:
$ 48.34万 - 项目类别:
Structure and Function of the LPLA2/LCAT Acyltransferase Family
LPLA2/LCAT 酰基转移酶家族的结构和功能
- 批准号:
8817382 - 财政年份:2014
- 资助金额:
$ 48.34万 - 项目类别:
RNA Aptamer-Based Screen for Selective Inhibitors of GRK2
基于 RNA 适体的 GRK2 选择性抑制剂筛选
- 批准号:
7929294 - 财政年份:2010
- 资助金额:
$ 48.34万 - 项目类别:
RNA Aptamer-Based Screen for Selective Inhibitors of GRK2
基于 RNA 适体的 GRK2 选择性抑制剂筛选
- 批准号:
8063896 - 财政年份:2010
- 资助金额:
$ 48.34万 - 项目类别:
Molecular basis for the regulation of G protein-coupled receptor kinases
G蛋白偶联受体激酶调节的分子基础
- 批准号:
8281593 - 财政年份:2009
- 资助金额:
$ 48.34万 - 项目类别:
Molecular basis for the regulation of G protein-coupled receptor kinases
G蛋白偶联受体激酶调节的分子基础
- 批准号:
7906035 - 财政年份:2009
- 资助金额:
$ 48.34万 - 项目类别:
Phosphorylation and G Protein Signaling Networks Gordon Conferences
磷酸化和 G 蛋白信号转导网络 Gordon Conferences
- 批准号:
8076873 - 财政年份:2009
- 资助金额:
$ 48.34万 - 项目类别:
Molecular basis for the regulation of G protein-coupled receptor kinases
G蛋白偶联受体激酶调节的分子基础
- 批准号:
7736619 - 财政年份:2009
- 资助金额:
$ 48.34万 - 项目类别:
相似海外基金
Design of chemical probes for hedgehog acyltransferase
Hedgehog酰基转移酶化学探针的设计
- 批准号:
2600595 - 财政年份:2022
- 资助金额:
$ 48.34万 - 项目类别:
Studentship
Identification of the glycolytic enzyme palmitoyl acyltransferase
糖酵解酶棕榈酰酰基转移酶的鉴定
- 批准号:
571756-2022 - 财政年份:2022
- 资助金额:
$ 48.34万 - 项目类别:
University Undergraduate Student Research Awards
The role of LYCAT acyltransferase in phagocytosis and immune function
LYCAT酰基转移酶在吞噬作用和免疫功能中的作用
- 批准号:
564899-2021 - 财政年份:2021
- 资助金额:
$ 48.34万 - 项目类别:
University Undergraduate Student Research Awards
Targeting a Human Acyltransferase for Broad-Spectrum Antivirals
靶向人类酰基转移酶的广谱抗病毒药物
- 批准号:
10223496 - 财政年份:2021
- 资助金额:
$ 48.34万 - 项目类别:
Hedgehog acyltransferase : structure and function in health and disease
Hedgehog酰基转移酶:健康和疾病中的结构和功能
- 批准号:
BB/T01508X/1 - 财政年份:2020
- 资助金额:
$ 48.34万 - 项目类别:
Research Grant
Protein acyltransferase mediated S-palmitoylation and its Importance in Innate Immunity and Lipid Metabolism.
蛋白质酰基转移酶介导的 S-棕榈酰化及其在先天免疫和脂质代谢中的重要性。
- 批准号:
401169 - 财政年份:2019
- 资助金额:
$ 48.34万 - 项目类别:
Operating Grants
Is transcription factor TEAD a missing protein lysine fatty acyltransferase?
转录因子 TEAD 是缺失的蛋白质赖氨酸脂肪酰基转移酶吗?
- 批准号:
19K22271 - 财政年份:2019
- 资助金额:
$ 48.34万 - 项目类别:
Grant-in-Aid for Challenging Research (Exploratory)
Basic research on the development of therapeutic agents for Alzheimer's disease using Acyl-CoA:cholesterol acyltransferase inhibitor
利用酰基辅酶A:胆固醇酰基转移酶抑制剂开发阿尔茨海默病治疗剂的基础研究
- 批准号:
19K07093 - 财政年份:2019
- 资助金额:
$ 48.34万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Defining the Molecular Architecture for Transmembrane Acylation by a Membrane Bound O-Acyltransferase
定义膜结合 O-酰基转移酶跨膜酰化的分子结构
- 批准号:
10246913 - 财政年份:2019
- 资助金额:
$ 48.34万 - 项目类别:
Characterization of Xenopus laevis DHAP acyltransferase
非洲爪蟾 DHAP 酰基转移酶的表征
- 批准号:
540689-2019 - 财政年份:2019
- 资助金额:
$ 48.34万 - 项目类别:
University Undergraduate Student Research Awards